Optimization of a Screening Method for Macroprolactinemia.

[1]  S. Petersenn.  Biochemical diagnosis in prolactinomas: some caveats , 2019, Pituitary.

[2]  N. Karavitaki,et al.  Hyperprolactinaemia , 2019, Journal of clinical medicine.

[3]  Ivana Zec,et al.  Optimizing laboratory defined macroprolactin algorithm , 2019, Biochemia medica.

[4]  A. Copperman,et al.  New insights into human prolactin pathophysiology: genomics and beyond. , 2019, Current opinion in obstetrics & gynecology.

[5]  J. Abucham,et al.  Controversial issues in the management of hyperprolactinemia and prolactinomas – An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism , 2018, Archives of endocrinology and metabolism.

[6]  M. Overgaard,et al.  Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia , 2017, Clinical chemistry and laboratory medicine.

[7]  S. Ezzat,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: CLINICAL RELEVANCE OF MACROPROLACTIN IN THE ABSENCE OR PRESENCE OF TRUE HYPERPROLACTINEMIA. , 2015, Endocrine Practice.

[8]  P. Chanson,et al.  New insights in prolactin: pathological implications , 2015, Nature Reviews Endocrinology.

[9]  P. Stanić,et al.  Importance of macroprolactinemia in hyperprolactinemia. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[10]  Thomas P. Smith,et al.  Determination of prolactin: the macroprolactin problem. , 2013, Best practice & research. Clinical endocrinology & metabolism.

[11]  N. Genov,et al.  Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance. , 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[12]  K. Veljkovic,et al.  Reporting of post-polyethylene glycol prolactin: precipitation by polyethylene glycol 6000 or polyethylene glycol 8000 will change reference intervals for monomeric prolactin , 2012, Annals of clinical biochemistry.

[13]  S. Orešković,et al.  Macroprolactinemia: new insights in hyperprolactinemia , 2012, Biochemia medica.

[14]  Tao He,et al.  Protein precipitation by polyethylene glycol: a generalized model based on hydrodynamic radius. , 2012, Journal of biotechnology.

[15]  Victor M Montori,et al.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[16]  C. Inagaki,et al.  Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia. , 2007, Endocrinology.

[17]  J. Wahlberg,et al.  Detection of molecular variants of prolactin in human serum, evaluation of a method based on ultrafiltration. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[18]  P. Cappabianca,et al.  Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas , 2006, Clinical endocrinology.

[19]  J. Gibney,et al.  Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. , 2003, Clinical chemistry.